Thermo Scientific Launches iCAP PRO Series

Designed to provide a fast, sensitive range of trace element analysis solutions capable of capturing the complete spectrum of high matrix samples in single run.

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Scientific launched a new series of inductively coupled plasma optical emission spectroscopy (ICP-OES) instruments for food and beverage, consumer safety, industrial, environmental and pharmaceutical laboratories.

The iCAP PRO Series ICP-OES platform is designed to provide a fast, sensitive range of trace element analysis solutions capable of capturing the complete spectrum of high matrix samples in a single run. According to the company, it goes from standby to start-up in five minutes, and the new instruments reduce gas consumption within a vertical dual-purged optical pathway interface that has lower installation requirements due to its standard wall socket and low extraction flow rate. 
 
“The analysis of trace elements in high matrix samples is essential for laboratory teams across a number of sectors to assure the quality, consistency and safety of products and the environment we live in, but it traditionally presents acute analytical and resource challenges that limit routine deployment,” said Adrian Holley, director, product marketing, trace element analysis, chromatography and mass spectrometry, Thermo Fisher Scientific. “The launch of the iCAP PRO Series ICP-OES platform helps laboratories bypass traditional sample preparation requirements and the need to undertake multiple measurements, providing a range of trace element analysis solutions that enhance workflow productivity and reduce cost-per-sample.”

According to the company, labs using the iCAP PRO Series ICP-OES instruments can reduce the number of measurements per run to obtain a complete spectrum,  increase analysis speeds and readout in a reduced time frame, maximize instrument uptime with minimal recalibration of the instrument as a result of highly stable optics and polychromator.
  
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters